- Home
- KAR vs NAMS Comparison
KAR vs NAMS Comparison
Compare KAR & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAR
- NAMS
- Stock Information
- Founded
- KAR 2006
- NAMS 2019
- Country
- KAR United States
- NAMS Netherlands
- Employees
- KAR N/A
- NAMS N/A
- Industry
- KAR Retail-Auto Dealers and Gas Stations
- NAMS Biotechnology: Pharmaceutical Preparations
- Sector
- KAR Consumer Discretionary
- NAMS Health Care
- Exchange
- KAR Nasdaq
- NAMS Nasdaq
- Market Cap
- KAR 2.6B
- NAMS 3.1B
- IPO Year
- KAR 2009
- NAMS N/A
- Fundamental
- Price
- KAR $27.32
- NAMS $32.86
- Analyst Decision
- KAR Hold
- NAMS Strong Buy
- Analyst Count
- KAR 5
- NAMS 9
- Target Price
- KAR $27.00
- NAMS $41.89
- AVG Volume (30 Days)
- KAR 932.5K
- NAMS 974.1K
- Earning Date
- KAR 11-05-2025
- NAMS 11-05-2025
- Dividend Yield
- KAR N/A
- NAMS N/A
- EPS Growth
- KAR 697.19
- NAMS N/A
- EPS
- KAR 0.73
- NAMS N/A
- Revenue
- KAR $1,856,600,000.00
- NAMS $64,006,000.00
- Revenue This Year
- KAR $5.00
- NAMS N/A
- Revenue Next Year
- KAR $4.69
- NAMS $1.67
- P/E Ratio
- KAR $37.55
- NAMS N/A
- Revenue Growth
- KAR 7.20
- NAMS 762.15
- 52 Week Low
- KAR $15.44
- NAMS $14.06
- 52 Week High
- KAR $30.93
- NAMS $34.62
- Technical
- Relative Strength Index (RSI)
- KAR 39.15
- NAMS 72.18
- Support Level
- KAR $26.95
- NAMS $27.15
- Resistance Level
- KAR $29.03
- NAMS $34.59
- Average True Range (ATR)
- KAR 0.57
- NAMS 1.47
- MACD
- KAR -0.17
- NAMS 0.50
- Stochastic Oscillator
- KAR 23.81
- NAMS 73.37
About KAR OPENLANE Inc.
Openlane Inc provides a digital marketplace for used vehicles, connecting sellers and buyers in North America and Europe for fast and transparent transactions. Its services include financing, repossessions, repairs, transportation, warranty, and inventory management. The company operates used-vehicle auctions and has two main segments: Marketplace and Finance, with majority revenue coming from the Marketplace segment, which to used vehicle remarketing, including marketplace services, remarketing, or make ready services and all are interrelated, synergistic elements along the auto remarketing chain. The Finance segment, through AFC engaged in business of providing short-term, inventory-secured financing to independent vehicle dealers.
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.